Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase II trial results for a combination of paclitaxel albumin-stabilized nanoparticle formulation, gemcitabine, and bevacizumab in metastatic breast cancer hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Avastin (bevacizumab)
• Gemzar (gemcitabine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-17